FRIEDL-NADERER JOHANNA (Chief Commercial Officer) sold 0.7% of their position (1.08K shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $25.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/8/2026ACC: 0001915598-26-000005
Officer· Chief Commercial Officer
Since Mar 2026
-1.08K
Net shares
Net seller
$25.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.08K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−900.00
Price / share
$24.35
Trade value
$21.91K
% of position
0.6%
9/4/2026
153.98K→153.08K
Common Stock
Direct
Shares
−185.00
Price / share
$18.88
Trade value
$3.49K
% of position
0.1%
9/8/2026
153.08K→152.90K
Total
Net shares
−1.08K
Net value
-$25.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/4/2026 | S · Sale | −900.00 | $24.35 | $21.91K | 0.6% | 153.98K | 153.08K |
| Common Stock Direct | 9/8/2026 | S · Sale | −185.00 | $18.88 | $3.49K | 0.1% | 153.08K | 152.90K |
| Total | −1.08K | -$25.41K | ||||||
Derivative Transactions0
No derivative transactions reported